Rise Advisors »

Sutro Biopharma shares owned by Rise Advisors

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by Rise Advisors from 13F filings

Historical chart of Rise Advisors investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by Rise Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by Rise Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $668 769 0.87
2025-06-30 $548 769 0.71

More positions owned by Rise Advisors

Vanguard Growth Etf 0 (VUG)
Vanguard Value Etf 0 (VTV)
Vanguard Core Bond Etf 0 (VCRB)
Janus Henderson Mortgage-backed Securities Etf 0 (JMBS)
Fidelity Total Bond Etf 0 (FBND)
Janus Henderson Small/mid Cap Growth Alpha Etf 0 (JSMD)
Janus Henderson Short Duration Income Etf 0 (VNLA)
Ft Vest Laddered Moderate Buffer Etf 0 (BUFZ)
Financial Select Sector Spdr Fund 0 (XLF)
Industrial Select Sector Spdr Fund 0 (XLI)
Nvidia Corporation 0 (NVDA)
Microsoft Corp 0 (MSFT)
Apple 0 (AAPL)
Berkshire Hathaway Inc Del Cl B 0 (BRK.B)
Energy Select Sector Spdr Fund 0 (XLE)

View all positions for Rise Advisors

Top funds holding Sutro Biopharma

Suvretta Capital Management
Kynam Capital Management
Millennium Management
Vanguard Group
Acadian Asset Management
Velan Capital Investment Management
Tang Capital Management
Merck & Co
Vestal Point Capital
Eversept Partners
Samsara BioCapital
Adage Capital Partners GP
UBS Group
BlackRock
Renaissance Technologies

View all funds holding Sutro Biopharma